Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants

Lei Yang; Xiaohui Zhang; Liren Wang; Shuming Yin; Biyun Zhu; Ling Xie; Qiuhui Duan; Huiqiong Hu; Rui Zheng; Yu Wei; Liangyue Peng; Honghui Han; Jiqin Zhang; Wenjuan Qiu; Hongquan Geng; Stefan Siwko; Xueli Zhang; Mingyao Liu; Dali Li

doi:10.1007/s13238-018-0568-x

Protein Cell ›› 2018, Vol. 9 ›› Issue (9) : 814 -819. DOI: 10.1007/s13238-018-0568-x

LETTER

Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants

Author information +

History +

PDF (1762KB)

Cite this article

Download citation ▾

Lei Yang, Xiaohui Zhang, Liren Wang, Shuming Yin, Biyun Zhu, Ling Xie, Qiuhui Duan, Huiqiong Hu, Rui Zheng, Yu Wei, Liangyue Peng, Honghui Han, Jiqin Zhang, Wenjuan Qiu, Hongquan Geng, Stefan Siwko, Xueli Zhang, Mingyao Liu, Dali Li. Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants. Protein Cell, 2018, 9(9): 814-819 DOI:10.1007/s13238-018-0568-x

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Frischmeyer PA, van Hoof A, O’Donnell K, Guerrerio AL, Parker R, Dietz HC (2002) An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 295:2258–2261.

[2]	Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551:464–471.

[3]	Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33:985–989.

[4]	Keeling KM, Xue X, Gunn G, Bedwell DM (2014) Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet 15:371–394.

[5]	Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK (2015a) Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol 33:1293–1298.

[6]	Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales APW, Li Z, Peterson RT, Yeh J-RJ (2015b) Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523:481–485.

[7]	Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420–424.

[8]	Kroos MA, Kirschner J, Gellerich FN, Hermans MMP, Van der Ploeg AT, Reuser AJJ, Korinthenberg R (2004) A case of childhood Pompe disease demonstrating phenotypic variability of p. Asp645Asn. Neuromuscul Disord 14:371–374.

[9]	Li X, Wang Y, Liu Y, Yang B, Wang X, Wei J, Lu Z, Zhang Y, Wu J, Huang X (2018) Base editing with a Cpf1-cytidine deaminase fusion. Nat Biotechnol 36:324–327.

[10]	Liu Z, Lu Z, Yang G, Yang G, Li G, Feng S, Liu Y, Li J, Yu W, Zhang Y (2018) Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing. Nat Commun 9:2338.

[11]	Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY (2016) Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science.

[12]	Ryu S-M, Koo T, Kim K, Lim K, Baek G, Kim S-T, Kim HS, Kim D, Lee H, Chung E (2017) Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat Biotechnol.

[13]	Shao Y, Wang L, Guo N, Wang S, Yang L, Li Y, Wang M, Yin S, Han H, Zeng L (2018) Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats. J Biol Chem.

[14]	Wang H, La Russa M, Qi LS (2016) CRISPR/Cas9 in genome editing and beyond. Annu Rev Biochem.

[15]	Zhou C, Zhang M, Wei Y, Sun Y, Sun Y, Pan H, Yao N, Zhong W, Li Y, Li W (2017) Highly efficient base editing in human tripronuclear zygotes. Protein Cell 8(10):772–775